MFDS — authorised 12 December 2005
- Marketing authorisation holder: INSMED
- Status: likely_approved
🇰🇷 MECASERMIN RINFABATE in South Korea
MFDS authorised MECASERMIN RINFABATE on 12 December 2005
Marketing authorisation
MECASERMIN RINFABATE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is MECASERMIN RINFABATE approved in South Korea?
Yes. MFDS authorised it on 12 December 2005.
Who is the marketing authorisation holder for MECASERMIN RINFABATE in South Korea?
INSMED holds the South Korean marketing authorisation.